Hypermarcas (OTCMKTS:HYPMY) Announces Earnings Results

Hypermarcas (OTCMKTS:HYPMY) issued its earnings results on Wednesday. The company reported $0.10 earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $383.13 million for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%.

Hypermarcas Stock Performance

Shares of OTCMKTS:HYPMY traded down $0.04 during mid-day trading on Friday, reaching $4.65. 27,313 shares of the company traded hands, compared to its average volume of 22,959. The company’s 50 day moving average price is $4.42 and its 200-day moving average price is $4.47. The firm has a market cap of $3.27 billion, a PE ratio of 9.69 and a beta of 0.75. Hypermarcas has a 52 week low of $3.71 and a 52 week high of $5.50. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Hypermarcas to a “hold” rating in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.